Capecitabine: Side Effects, Dosages, Treatment, Interactions‌
Capecitabine, sold below the brand name Xeloda among others, is a chemotherapy medication utilized to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often utilized composed with docetaxel.It is taken by mouth. Common side effects contain abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects contain blood clotting problems, allergic reactions, heart problems such as cardiomyopathy, and low blood cell counts. It is not suggested in people with kidney problems. Use during pregnancy may effect in harm to the baby.Capecitabine, inside the body, is transformed to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications called as fluoropyrimidines, which also contains 5-fluorouracil and tegafur. Development in Capecitabine Market: Global Capecitabine Market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2019–2026.
Competitive Landscape: Some of the major Companies in the Capecitabine Market are Fresenius SE & Co. KGaA, Genentech, Inc., Dr Reddy Laboratories Ltd., Cipla Inc., Accord Healthcare Ltd.,